Rapid formation of functional muscle in vitro using fibrin gels.

The transition of a muscle cell from a differentiated myotube into an adult myofiber is largely unstudied. This is primarily due to the difficulty of isolating specific developmental stimuli in vivo and the inability to maintain viable myotubes in culture for sufficient lengths of time. To address these limitations, a novel method for rapidly generating three-dimensional engineered muscles using fibrin gel casting has been developed. Myoblasts were seeded and differentiated on top of a fibrin gel. Cell-mediated contraction of the gel around artificial anchors placed 12 mm apart culminates 10 days after plating in a tubular structure of small myotubes (10-microm diameter) surrounded by a fibrin gel matrix. These tissues can be connected to a force transducer and electrically stimulated between parallel platinum electrodes to monitor physiological function. Three weeks after plating, the three-dimensional engineered muscle generated a maximum twitch force of 329 +/- 26.3 microN and a maximal tetanic force of 805.8 +/- 55 microN. The engineered muscles demonstrated normal physiological function including length-tension and force-frequency relationships. Treatment with IGF-I resulted in a 50% increase in force production, demonstrating that these muscles responded to hormonal interventions. Although the force production was maximal at 3 wk, constructs can be maintained in culture for up to 6 wk with no intervention. We conclude that fibrin-based gels provide a novel method to engineer three-dimensional functional muscle tissue and that these tissues may be used to model the development of skeletal muscle in vitro.

[1]  Richard C. Strohman,et al.  Myogenesis and histogenesis of skeletal muscle on flexible membranes in vitro , 1990, In Vitro Cellular & Developmental Biology.

[2]  T. Matsuda,et al.  Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues. , 1998, Cell transplantation.

[3]  M. Urbanchek,et al.  Specific force deficit in skeletal muscles of old rats is partially explained by the existence of denervated muscle fibers. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  R G Dennis,et al.  Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. , 2001, American journal of physiology. Cell physiology.

[5]  Herman H. Vandenburgh,et al.  Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel , 1988, In Vitro Cellular & Developmental Biology.

[6]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[7]  S. J. Wilson,et al.  A critical period for formation of secondary myotubes defined by prenatal undernourishment in rats. , 1988, Development.

[8]  T. Matsuda,et al.  Hybrid muscular tissues: preparation of skeletal muscle cell-incorporated collagen gels. , 1997, Cell transplantation.

[9]  H. Vandenburgh,et al.  Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. , 1999, Human gene therapy.

[10]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[11]  R. Dennis,et al.  Glucose transporter content and glucose uptake in skeletal muscle constructs engineered in vitro , 2003, In Vitro Cellular & Developmental Biology - Animal.

[12]  Harold Weintraub,et al.  Transfection of a DNA locus that mediates the conversion of 10T1 2 fibroblasts to myoblasts , 1986, Cell.

[13]  F. Booth,et al.  Insulin-like growth factor-induced transcriptional activity of the skeletal alpha-actin gene is regulated by signaling mechanisms linked to voltage-gated calcium channels during myoblast differentiation. , 2004, Endocrinology.

[14]  O. Delbono Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. , 2000, The journal of nutrition, health & aging.

[15]  D. Powell,et al.  Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin* , 1999, The Journal of Biological Chemistry.

[16]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[17]  A. Sahni,et al.  Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin* , 1998, The Journal of Biological Chemistry.

[18]  F. Haddad,et al.  The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. , 1996, Journal of applied physiology.

[19]  J. Florini,et al.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. , 1991, Molecular endocrinology.

[20]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[21]  H. Vandenburgh,et al.  Recombinant Vascular Endothelial Growth Factor Secreted From Tissue-Engineered Bioartificial Muscles Promotes Localized Angiogenesis , 2001, Circulation.

[22]  A. Irintchev,et al.  Ectopic skeletal muscles derived from myoblasts implanted under the skin. , 1998, Journal of cell science.

[23]  J. Faulkner,et al.  Functional development of engineered skeletal muscle from adult and neonatal rats. , 2001, Tissue engineering.

[24]  H. Vandenburgh,et al.  Bioartificial muscles in gene therapy. , 2002, Methods in molecular medicine.

[25]  J. Younger,et al.  Characteristics of an Albumin Dialysate Hemodiafiltration System for the Clearance of Unconjugated Bilirubin , 1997, ASAIO journal.

[26]  H. Vandenburgh,et al.  Mechanical stimulation improves tissue-engineered human skeletal muscle. , 2002, American journal of physiology. Cell physiology.

[27]  Robert G. Dennis,et al.  Mesenchymal Cell Culture , 2002 .

[28]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[29]  R T Tranquillo,et al.  Self-organization of tissue-equivalents: the nature and role of contact guidance. , 1999, Biochemical Society symposium.

[30]  G. Adams,et al.  Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. , 1998, Journal of applied physiology.

[31]  T. Matsuda,et al.  Tissue Engineering of Skeletal Muscle Highly Dense, Highly Oriented Hybrid Muscular Tissues Biomimicking Native Tissues , 1997, ASAIO journal.

[32]  R. Tranquillo,et al.  ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[33]  T. Matsuda,et al.  Muscular tissue engineering: capillary-incorporated hybrid muscular tissues in vivo tissue culture. , 1998, Cell transplantation.

[34]  Robert G. Dennis,et al.  Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro , 2000, In Vitro Cellular & Developmental Biology - Animal.

[35]  A. J. Harris,et al.  Formation of myotubes in aneural rat muscles. , 1993, Developmental biology.

[36]  H. Werner,et al.  Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor* , 1997, The Journal of Biological Chemistry.

[37]  H. Vandenburgh,et al.  Therapeutic Potential of Implanted Tissue‐Engineered Bioartificial Muscles Delivering Recombinant Proteins to the Sheep Heart , 2002, Annals of the New York Academy of Sciences.

[38]  A. Sahni,et al.  FGF‐2 but not FGF‐1 binds fibrin and supports prolonged endothelial cell growth , 2003, Journal of thrombosis and haemostasis : JTH.

[39]  R. Close Dynamic properties of fast and slow skeletal muscles of the rat during development , 1964, The Journal of physiology.

[40]  H. Vandenburgh,et al.  A simplified method for tissue engineering skeletal muscle organoids in vitro , 1997, In Vitro Cellular & Developmental Biology - Animal.

[41]  A. Sahni,et al.  Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. , 2000, Blood.